LANXESS presents its disinfection portfolio for the first time at Medica 2025

  • Rely+On infection control portfolio for the medical sector
  • Disinfection solutions combating antimicrobial resistance
  • Advanced formulations for rapid deployment
  • LANXESS booth: Messe Duesseldorf, Hall 11, #E36
Cologne
RelyOn Virkon Product Shoot
LANXESS
LANXESS will present its Rely+On infection control portfolio and range of active ingredients at Medica 2025. Photo: LANXESS

LANXESS will present its Rely+On infection control portfolio and range of active ingredients at Medica 2025 from November 17 to 20. By participating in the world’s largest medical trade fair for the first time, the specialty chemicals company is emphasizing the performance of its disinfectant products portfolio in the medical sector and strengthening its presence in this segment.

Disinfection solutions against antimicrobial resistance

LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions, including Rely+On Virkon, a globally recognized broad-spectrum disinfectant used in hospitals, medical laboratories, and public health facilities, and Rely+On PeraSafe, a leading product for the safe and rapid decontamination of medical instruments. Both products meet rigorous international standards and have demonstrated effective performance within EN efficacy testing standards, with Rely+On particularly suited for use in emergency outbreak scenarios involving SARS-CoV-2, avian influenza, norovirus, and other emerging pathogens.

Advanced formulations for rapid deployment

Alongside LANXESS will be presenting innovative, powerful active ingredients for formulators, such as Oxone (potassium monopersulfate), synthetic phenolic compounds, and aldehyde-based antimicrobials to ensure proven effectiveness and user safety. These products are designed for quick deployment to support decontamination needs in healthcare, veterinary, and transport settings. This enables institutions and authorities to respond quickly to emergencies with minimal operational disruption.

Rely+On portfolio in use on all continents

Rely+On is LANXESS’ trusted brand of high-performance disinfection products, engineered to meet the evolving needs of healthcare and institutional providers. Rely+On solutions are adopted by governments and NGOs worldwide for emergency preparedness and outbreak containment. Thanks to their favorable safety profiles, the products allow for frequent use, making them ideal for healthcare and institutional providers across the globe.

Expert consultation and latest advancements

Throughout Medica 2025, LANXESS’ infection control experts will be available to showcase products, share technical expertise, and discuss the latest advancements in disinfection science. Visitors are invited to consult with specialists to receive tailored solutions addressing hospital infection prevention, emergency response, and operational safety challenges.

Further information on Rely+On products and applications is available at https://lanxess.com/en/products-and-brands/brands/rely-on-disinfection.

Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

MORE ABOUT THIS TOPIC

PRESS RELEASE
Medica, RelyOn, RelyOn Virkon, RelyOn PeraSafe, RelyOn Disinfection, Disinfection

LANXESS presents its disinfection portfolio for the first time at Medica 2025

November 10, 2025
PRESS RELEASE
Wear on gears on gear stress test rig (FZG)

Sustainable lubricant additive for extreme pressure applications

October 30, 2025
PRESS RELEASE
production plant O10 Leverkusen Saltigo reactors

Saltigo at CPHI 2025: Europe`s Reliable CDMO Partner with a Broad Technology Portfolio

October 22, 2025
PRESS RELEASE
Logo K 2025 mit Datum

LANXESS at K 2025: Focus on additives, colorants and pigments

October 03, 2025
PRESS RELEASE
Sustainability.

LANXESS reduces CO₂ footprint for products at Botlek site

September 17, 2025